Plain-English translation of NCT07243249 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a rapid diagnostic test that can identify three common respiratory viruses—COVID-19, influenza, and RSV—in less than 15 minutes helps doctors make better decisions about prescribing antibiotics. Right now, doctors often prescribe antibiotics even when a patient has a viral infection (which antibiotics can't treat), because it's hard to know quickly whether an infection is viral or bacterial. The test aims to give doctors answers during your visit so they can avoid unnecessary antibiotics.
Most respiratory infections are caused by viruses, not bacteria, yet antibiotics are prescribed for many of them anyway. This overuse of antibiotics is a major global health problem because it makes bacteria stronger and harder to treat. By helping doctors quickly identify when an infection is viral, this test could reduce unnecessary antibiotic use, prevent harmful side effects, and save healthcare costs.
You likely qualify if…
You likely don't qualify if…
If you're selected for the study, you'll visit a community clinic or doctor's office with respiratory symptoms. One group will receive the standard care (your doctor decides about antibiotics as usual). The other group will have the rapid triplex test performed during your visit—a simple swab that gives results in about 15 minutes—and your doctor will use those results to guide whether antibiotics are appropriate. Either way, the study team will track whether you were prescribed antibiotics and monitor how you recover.
AI-generated summary from trial data · Aug 20, 2026 · Not medical advice
France